Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010315 · ClinicalTrials.gov registry record
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
A clinical trial of Liver Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07010315 is a study of Liver Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 40 participants, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07010315, a study of Liver Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop and test liver cancer prevention educational material.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Testing
- BEHAVIORAL Usability Testing
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07010315
The ClinicalTrials.gov registry entry for NCT07010315 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 447-participant average among 78 other Liver Cancer trials with a reported enrollment target (91% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Testing is the first listed.
NCT07010315 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07010315 about?
NCT07010315 is a clinical study titled "Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention". To develop and test liver cancer prevention educational material.
What is the current status of trial NCT07010315?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-05-01. Estimated completion is 2027-04-30.
What conditions does trial NCT07010315 study?
This clinical trial studies the following conditions: Liver Cancer.
What interventions are being tested in trial NCT07010315?
The interventions under investigation include: Cognitive Testing (BEHAVIORAL), Usability Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07010315?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility Study of CBCT for IGRT in Cancer Patients
RECRUITING · NA
-
Collection of Blood From Patients With Cancer
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
RECRUITING · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.